explain the whole muscle physiology include all details present in higher books like anatomy and physiology and clinical and research papers and also make 50 high yield, mOst difficult and conceptual questions

Reading File

Finding Sources

Searching PubMed

skeletal muscle physiology contraction mechanism

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Searching Images

sarcomere structure actin myosin diagram

Reading File

COMPLETE MUSCLE PHYSIOLOGY - MASTER REFERENCE

Sources: Guyton & Hall Textbook of Medical Physiology, Costanzo Physiology 7e, Miller's Review of Orthopaedics 9e, Rheumatology 2-Volume Set (Elsevier), Morgan & Mikhail's Clinical Anesthesiology, and recent PubMed reviews (2023-2024)

PART 1 - SKELETAL MUSCLE

1. GROSS ORGANIZATION AND CONNECTIVE TISSUE FRAMEWORK

Skeletal muscle constitutes approximately 40% of body weight and is the primary tissue responsible for movement, joint protection, and maintaining upright posture.

Connective tissue layers (from deep to superficial):

Endomysium - a fine layer of connective tissue surrounding each individual muscle fiber
Perimysium - surrounds bundles of fibers called fasciculi (each fasciculus contains up to ~150 fibers)
Epimysium (fascia) - surrounds the entire muscle

The length of individual fibers varies enormously - from a few millimeters to nearly 30 cm, depending on body location. Fiber diameter ranges from 10 to 80 micrometers.

Rheumatology 2-Volume Set (Elsevier), p. 1421
Guyton & Hall Textbook of Medical Physiology, p. 93

2. ULTRASTRUCTURE: FROM FIBER TO SARCOMERE

Each muscle fiber (a multinucleated cell) contains myofibrils, and each myofibril contains myofilaments - the actual contractile proteins.

Protein composition of myofilaments:

Myosin + Actin = 85% of all protein content
Supporting/regulatory proteins: tropomyosin, troponin complex, desmin, titin

The Sarcomere - The Fundamental Contractile Unit

The sarcomere extends from Z disk to Z disk. Key structural landmarks:

Band/Zone	Contents	Behavior on Contraction
A band	Full length of myosin (thick) filaments, including overlap zone	Does NOT change length
I band	Actin only (no myosin overlap)	SHORTENS (narrows)
H zone	Myosin only (no actin overlap)	SHORTENS (narrows)
M line	Center of myosin filaments - structural support	-
Z disk	Anchors actin filaments; marks boundary of sarcomere	Z disks move closer together

Critical concept: During contraction, the filaments themselves do NOT shorten. Only the I band and H zone shorten, and the distance between Z disks decreases. This is the Sliding Filament Theory (Huxley & Hanson, 1954).

Thin filament (actin) structure:

F-actin = polymerized G-actin monomers in a double-helical strand
Tropomyosin lies in the grooves of the actin helix, physically blocking myosin-binding sites at rest
Troponin complex = Troponin I (inhibitory), Troponin T (tropomyosin-binding), Troponin C (calcium-binding) - attached every 7 actin monomers

Thick filament (myosin) structure:

~200 myosin molecules per filament
Each myosin has a tail (structural) and a head (cross-bridge with ATPase activity)
Myosin ATPase activity (mATPase) determines contraction speed - the rate-limiting enzyme for contraction velocity

Titin (connectin): Giant elastic protein running from Z disk to M line along each myosin filament. Functions as a "molecular spring" that:

Maintains sarcomere integrity
Centers myosin in the sarcomere
Provides passive tension at long muscle lengths
Plays a role in signaling for muscle protein synthesis

Guyton & Hall Textbook of Medical Physiology, p. 93-98
Structural Biochemistry of Muscle Contraction, Ann Rev Biochem 2023 - PMID 37001141

3. THE NEUROMUSCULAR JUNCTION (MOTOR END PLATE)

The neuromuscular junction (NMJ) is where a lower motor neuron makes synaptic contact with a muscle fiber.

Motor Unit = one alpha-motoneuron + ALL muscle fibers it innervates.

Small, precise muscles: very few fibers per unit (extraocular muscles: < 5 fibers/unit)
Large, powerful muscles: many fibers per unit (gastrocnemius: ~1800 fibers/unit)
Each muscle fiber is innervated by only one axon, but one axon can innervate many fibers

Sequence of events at the NMJ:

Action potential propagates to the axon terminal bouton
Depolarization opens voltage-gated Ca2+ channels in the presynaptic terminal
Ca2+ entry triggers exocytosis of acetylcholine (ACh) from presynaptic vesicles
ACh diffuses across the synaptic cleft (50 nm wide)
ACh binds nicotinic ACh receptors (nAChRs) on the motor end plate (postsynaptic sarcolemma)
nAChRs are ligand-gated Na+/K+ channels - opening causes net Na+ influx, generating an end-plate potential (EPP)
The EPP triggers an action potential in the sarcolemma
Acetylcholinesterase (in the synaptic cleft and basal lamina) rapidly degrades ACh, terminating the signal

Safety factor of the NMJ: The EPP is normally ~3x larger than needed to trigger an action potential, providing a built-in safety margin.

Key clinical correlations:

Myasthenia gravis: IgG antibodies against nAChRs - reduces receptor density, EPP may fail to reach threshold; initially ptosis and diplopia, weakness worsens with use
Lambert-Eaton syndrome: Antibodies against presynaptic voltage-gated Ca2+ channels - reduced ACh release; paradoxically improves with repeated stimulation (Ca2+ builds up)
Botulinum toxin: Cleaves SNARE proteins (SNAP-25, synaptobrevin) - blocks presynaptic ACh release. Therapeutically used to reduce spasticity (e.g., in cerebral palsy) and in cosmetic treatments
Organophosphates / Neostigmine: Inhibit acetylcholinesterase - ACh accumulates in cleft
Miller's Review of Orthopaedics 9e, p. 69
Guyton & Hall Textbook of Medical Physiology, p. 93

4. ACTION POTENTIAL PROPAGATION AND THE T-TUBULE SYSTEM

Sarcolemmal action potential:

Resting membrane potential: approximately -85 mV (more negative than nerve due to higher K+ permeability)
Action potential triggered by EPP (threshold: ~ -50 to -60 mV)
Propagates at 3-5 m/s along the sarcolemma in both directions from the NMJ

Transverse (T) tubule system:

T tubules are invaginations of the sarcolemma that plunge transversely into the fiber
They contain extracellular fluid (lumen open to outside) - therefore, changes in ECF composition (e.g., Ca2+ concentration) directly affect the interior signaling environment
In mammalian skeletal muscle: two T tubules per sarcomere, located at the A-I band junctions
(In cardiac muscle: one T tubule per sarcomere, at the Z disk; cardiac T tubules are 5x wider in diameter)
T tubules form triads with the terminal cisternae of the sarcoplasmic reticulum on either side

Sarcoplasmic reticulum (SR):

Extensive membranous network surrounding each myofibril
Two distinct parts: (1) terminal cisternae (lateral sacs abutting T tubules) and (2) longitudinal tubules connecting cisternae
Contains a very high concentration of stored Ca2+ (maintained by SERCA pump - Sarcoplasmic-Endoplasmic Reticulum Ca2+-ATPase)
Guyton & Hall Textbook of Medical Physiology, p. 109

5. EXCITATION-CONTRACTION (E-C) COUPLING

This is the pivotal bridge between the electrical event (action potential) and the mechanical event (contraction).

Step-by-step sequence:

Action potential reaches the T tubule and spreads to its depths
Voltage change is sensed by dihydropyridine receptors (DHPRs) - voltage-gated L-type Ca2+ channels in the T-tubule membrane
In skeletal muscle, DHPRs are mechanically coupled (physical contact) to ryanodine receptors (RyR1) in the SR terminal cisternae - DHPRs act as voltage sensors, directly opening RyR1 without requiring Ca2+ influx
RyR1 opens: massive Ca2+ efflux from SR into sarcoplasm
Sarcoplasmic Ca2+ concentration rises from ~10^-7 M (resting) to ~10^-5 M (activated) - a 100-fold increase
Ca2+ binds Troponin C (Kd ~1 µM) - conformational change in troponin complex
Troponin I releases its inhibitory hold on actin; tropomyosin shifts laterally (~1.5 nm) in the groove of the actin helix
Myosin-binding sites on actin are exposed
Cross-bridge cycle begins (see below)

Relaxation:

Ca2+ is actively pumped back into SR by SERCA pump (using ATP) - sarcoplasmic Ca2+ falls
Troponin C loses Ca2+, tropomyosin re-blocks actin sites
Cross-bridges detach (requires ATP)
Muscle returns to resting length due to elastic recoil (titin, connective tissue)

Skeletal vs. Cardiac E-C Coupling (key difference):

Skeletal: DHPR is purely a voltage sensor; Ca2+ comes entirely from SR; does not depend on extracellular Ca2+ for each contraction
Cardiac: DHPR opens as a true Ca2+ channel; Ca2+ entry from ECF triggers Ca2+-induced Ca2+ release (CICR) from SR via RyR2. Cardiac contraction IS dependent on extracellular Ca2+ (heart stops in Ca2+-free solution)
Guyton & Hall Textbook of Medical Physiology, p. 109, 125
Costanzo Physiology 7e, p. 150
Morgan & Mikhail's Clinical Anesthesiology 7e

6. THE CROSS-BRIDGE CYCLE (LYMN-TAYLOR CYCLE)

This is the molecular motor cycle that converts ATP chemical energy into mechanical force:

State 1 - Rigor (pre-ATP):

Myosin head bound tightly to actin; no ATP
"Rigor" conformation: characteristic of rigor mortis when ATP is depleted

State 2 - Detachment:

ATP binds to myosin head at the ATP-binding site (cleft in the head)
Myosin-actin affinity drops dramatically; head detaches from actin

State 3 - Cocking (power stroke preparation):

ATP is hydrolyzed to ADP + Pi (but products remain on head)
Myosin head undergoes conformational change to the "cocked" (high-energy) position - head rotates ~70° perpendicular to actin axis
Head moves to a new site on actin, 3 subunits away (~10 nm along filament)

State 4 - Weak binding:

Myosin head binds to actin weakly (with ADP + Pi still on board)

State 5 - Power stroke:

Pi is released first - this is the trigger for the power stroke
Myosin head pivots/tilts by ~45°, pulling the actin filament ~10 nm toward the M line (center)
ADP is then released - this is the step that commits the head to strong binding

State 6 - Strong binding / Rigor:

Cross-bridge in rigor conformation again, awaiting new ATP
If Ca2+ is still high and ATP available, the cycle repeats

One cross-bridge power stroke generates ~1-4 pN of force and moves actin ~10 nm. Dozens to hundreds of cross-bridges cycle asynchronously, producing smooth, sustained tension.

Force generation is proportional to the number of cross-bridges in the strong-binding state, which depends on Ca2+ concentration and sarcomere length.

Guyton & Hall Textbook of Medical Physiology, p. 95
Molecular mechanisms of muscle contraction: A historical perspective, J Biomech 2023 - PMID 37290181

7. LENGTH-TENSION RELATIONSHIP

At a given level of activation, the force a muscle produces depends critically on sarcomere length:

Sarcomere Length	Cross-Bridge Overlap	Active Tension
< 1.6 µm (over-compressed)	Z disks collide with myosin; actin filaments from opposite sides overlap and interfere	Very low
1.6 - 2.0 µm	Suboptimal overlap (actin not fully covering myosin binding sites)	Increasing
~2.0 - 2.2 µm	OPTIMAL overlap - maximal cross-bridge formation	Maximal (100%)
2.2 - 3.6 µm	Decreasing overlap	Decreasing
> 3.6 µm	No overlap (actin and myosin completely separated)	Zero

Passive tension (from titin and connective tissue) rises steeply at lengths > ~2.2-2.4 µm. The total tension = active + passive.

In vivo, most muscles operate near their optimal sarcomere length.

8. FORCE-VELOCITY RELATIONSHIP

The relationship between the load on a muscle and its velocity of shortening is an inverse hyperbola (Hill's equation):

No load (zero): maximum velocity (Vmax) - all cross-bridges cycle at maximum rate
Maximum load (isometric): velocity = zero, maximum isometric force (P0)
Intermediate loads: velocity is inversely proportional to load

Vmax depends on myosin ATPase activity - fast fibers have higher ATPase = higher Vmax.

Eccentric contraction (muscle lengthening under load): Produces greater force than maximum isometric contraction - this is the basis of plyometric training benefits and also of most exercise-induced muscle damage.

Maximum efficiency of muscle contraction is less than 25% of chemical energy input (Guyton & Hall) - maximum efficiency occurs at approximately 30% of Vmax.

9. MOTOR UNIT SUMMATION AND TETANUS

Twitch: A single action potential produces a single brief contraction event.

Summation (temporal): If a second action potential arrives before the muscle has fully relaxed from the first twitch, the second contraction is added onto the residual tension from the first. Tension is cumulative.

Tetanus: High-frequency stimulation (> ~20-40 Hz for slow fibers, > ~80-100 Hz for fast fibers) produces a fused, sustained maximal contraction because Ca2+ remains continuously elevated.

Tetanic force is 4-5x the single twitch force because cross-bridges are maximally recruited.

Recruitment (spatial summation): The nervous system grades force by progressively recruiting more motor units.

Henneman Size Principle: Small motor units (type I, slow) are recruited first (lowest threshold); larger units (type II, fast) are recruited at higher levels of activation

10. MUSCLE FIBER TYPES

Based on myosin heavy-chain (MHC) isoform and mATPase activity, three major types exist (with clinical relevance):

Property	Type I (Slow Oxidative)	Type IIA (Fast Oxidative-Glycolytic)	Type IIB/IIX (Fast Glycolytic)
MHC Isoform	MHC-I (slow)	MHC-IIa	MHC-IIb/IIx
mATPase activity	Low	High	Very High
Contraction speed	Slow	Fast	Very Fast
Fatigue resistance	Very High	Moderate	Low (fatigues rapidly)
Mitochondrial density	High	Moderate	Low
Metabolic pathway	Aerobic (oxidative)	Mixed	Anaerobic (glycolytic)
Myoglobin content	High (red)	Moderate	Low (white)
Capillary density	High	Moderate	Low
Use	Postural, endurance	Sustained power	Explosive, sprint
Athletes	Marathon runners	Mixed	Sprinters, power athletes
Histology	Type I = dark at pH 4.3 staining	Intermediate	Type II = dark at pH 9.4 staining

Clinical note: With aging, type II fibers preferentially atrophy - loss of fast-twitch fibers contributes to sarcopenia. Women have relatively more type I fibers and smaller type II fibers than men. Type IIC fibers are transition fibers expressing both fast and slow MHC isoforms; they can differentiate into either type I or type II.

Rheumatology 2-Volume Set, p. 1420
Miller's Review of Orthopaedics 9e, p. 70

11. ENERGETICS OF MUSCLE CONTRACTION

ATP is the direct energy currency. Resting muscle contains only ~4 mM ATP (enough for 1-2 seconds of maximal contraction). Three sequential energy systems replenish ATP:

System 1 - Phosphocreatine (PCr) System:

PCr + ADP → Creatine + ATP (catalyzed by creatine kinase)
Very fast (immediate energy); limited stores (~8-10 seconds of max effort)
Basis of creatine supplementation in sports

System 2 - Anaerobic Glycolysis:

Glucose/glycogen → pyruvate → lactate + ATP
Fast (seconds to ~2 minutes); no oxygen required
Net yield: 2 ATP from glucose, 3 ATP from glycogen
Lactate (not lactic acid per se) accumulates; contributes to metabolic acidosis and fatigue

System 3 - Oxidative Phosphorylation:

Pyruvate → acetyl-CoA → Krebs cycle → oxidative phosphorylation
Slow but virtually unlimited; high ATP yield (~30-32 ATP/glucose)
Requires oxygen - dominant in type I fibers and sustained exercise

ATP is used for:

Cross-bridge cycling (the power stroke)
Ca2+ reuptake by SERCA pump back into SR
Na+/K+ ATPase to restore membrane potential

Rigor mortis occurs within hours of death due to complete ATP depletion - without ATP, myosin cannot detach from actin, locking cross-bridges in the rigor state. Resolution ~15-25 hours later when proteins are degraded by autolysis.

Guyton & Hall Textbook of Medical Physiology, p. 97-98, 103

12. MUSCLE MECHANICS - TYPES OF CONTRACTION

Type	Definition	Example	Force
Isometric	Muscle activated but length does not change	Holding a weight still	Moderate to high
Isotonic (concentric)	Muscle shortens at constant tension	Bicep curl upward	Variable
Eccentric	Muscle lengthens under load (active elongation)	Lowering a weight slowly	Greatest force
Auxotonic	Both tension and length change (most real-world contractions)	Walking	Variable

Isometric force (P0) is proportional to physiological cross-sectional area (PCSA), not length. Contraction velocity is determined by fiber length (number of sarcomeres in series).

13. MUSCLE FATIGUE

Fatigue is a reversible decline in force/power output. Multiple mechanisms:

Peripheral fatigue (within the muscle):
- Pi accumulation (from ATP hydrolysis) - directly impairs myosin head transition and reduces Ca2+ sensitivity of troponin
- H+ accumulation (acidosis) - inhibits phosphofructokinase (glycolysis), impairs Ca2+ binding to troponin C
- Ca2+ handling dysfunction - SR Ca2+ depletion, RyR inactivation
- Glycogen depletion (endurance exercise)
- Free radical/ROS accumulation
Central fatigue:
- Reduced neural drive from CNS to motor neurons
- Altered neurotransmitter levels (serotonin, dopamine)

14. MUSCLE DEVELOPMENT, REGENERATION, AND ADAPTATION

Development:

Myoblasts (precursor cells, derived from mesoderm) proliferate, then fuse into multinucleated myotubes, which mature into muscle fibers
Fiber type is established during embryonic development and appears to be genetically determined

Satellite cells:

Muscle-specific stem cells that lie between the sarcolemma and basal lamina
Normally quiescent; activated by injury or exercise stress
Provide new myonuclei for hypertrophy and repair

Atrophy and denervation:

Disuse or denervation causes rapid atrophy - begins almost immediately
After ~2 months of denervation, degenerative changes appear
If nerve regrows within 3 months: full recovery possible
After 1-2 years: permanent fibrous/fatty replacement

Macromotor units in polio: Surviving motor neurons branch to innervate paralyzed fibers, forming oversized motor units with up to 5x normal fiber count - reduces fine control but restores some strength

Guyton & Hall Textbook of Medical Physiology, p. 103
Rheumatology 2-Volume Set, p. 1421

PART 2 - CARDIAC MUSCLE

15. CARDIAC MUSCLE - STRUCTURAL AND PHYSIOLOGICAL DIFFERENCES

Feature	Skeletal	Cardiac
Nuclei	Multiple (peripheral)	1-2 (central)
Striations	Present	Present
Intercalated discs	Absent	Present (gap junctions = electrical syncytium)
T-tubule diameter	Narrow	~5x wider (25x the volume)
T-tubule location	A-I junction (2 per sarcomere)	Z disk (1 per sarcomere)
Ca2+ source for contraction	SR only (DHPR mechanical coupling)	SR + ECF influx (CICR via RyR2)
Response to Ca2+-free solution	Can still contract briefly	Stops beating immediately
Refractory period	Short (tetanus possible)	Very long (tetanus impossible - protects cardiac output)
Nervous control	Voluntary (somatic)	Involuntary (autonomic modulation)
Frank-Starling mechanism	Does not operate significantly	Fundamental (stretch → increased force)

Ca2+-induced Ca2+ release (CICR) in cardiac muscle:

Action potential depolarizes T tubule
L-type Ca2+ channels (DHPRs) in T tubule open - small Ca2+ influx ("trigger Ca2+")
This trigger Ca2+ activates RyR2 in SR - massive Ca2+ release
Total sarcoplasmic Ca2+ rises to activate troponin and produce contraction
Force is proportional to intracellular [Ca2+] - therefore drugs/hormones/NTs that alter trigger Ca2+ or SR Ca2+ stores change contractility (inotropy)

Relaxation in cardiac muscle:

SERCA (SR pump) reuptakes Ca2+ into SR
Na+/Ca2+ exchanger (NCX) extrudes Ca2+ that entered from ECF using the inward Na+ gradient
Ca2+ ATPase in sarcolemma also contributes
Guyton & Hall Textbook of Medical Physiology, p. 125
Costanzo Physiology 7e, p. 150

PART 3 - SMOOTH MUSCLE

16. SMOOTH MUSCLE PHYSIOLOGY

Types of Smooth Muscle

Unitary (visceral) smooth muscle: Large sheets of cells electrically coupled by gap junctions; behave as a functional syncytium; exhibit spontaneous rhythmic activity (pacemaker potentials); found in gut, uterus, ureter
Multi-unit smooth muscle: Individual cells not electrically coupled; require individual innervation for each fiber; fine control; found in iris, piloerectors, large blood vessel walls

Structural Differences from Skeletal Muscle

No sarcomeres - no striation
Actin filaments attach to dense bodies (cytoplasmic) and dense bands (membrane-associated) - homologous to Z disks
Side-polar myosin filaments: Cross-bridges on opposite sides of the myosin filament point in opposite directions - this allows smooth muscle to shorten by up to 80% of its resting length (versus < 30% for skeletal muscle)
5-10x more actin than myosin filaments

Smooth Muscle Contraction Mechanism - Key Difference: NO TROPONIN

Instead of troponin, smooth muscle uses calmodulin + myosin light-chain kinase (MLCK):

Ca2+ (from SR and/or ECF) rises in sarcoplasm
Ca2+ binds calmodulin (4 Ca2+ per calmodulin)
Ca2+-calmodulin complex activates MLCK
MLCK phosphorylates the regulatory light chain of myosin (at Ser-19)
Phosphorylated myosin can now bind actin and cycle
Myosin phosphatase (MLCP) dephosphorylates myosin → relaxation

Calcium sensitization (clinical target): Rho kinase inhibits MLCP, maintaining myosin phosphorylation even at lower Ca2+ - this is the basis of vasospasm (e.g., in pulmonary hypertension). Rho kinase inhibitors (fasudil) are used clinically.

Smooth Muscle Tone and Regulation

Smooth muscle maintains tonic contraction with low energy cost (latch state - slowly cycling cross-bridges)
Regulated by:
- Autonomic nervous system (norepinephrine via α/β receptors, ACh via muscarinic)
- Hormones (angiotensin II, endothelin, aldosterone)
- Local metabolites (CO2, O2, pH, K+)
- Nitric oxide (NO): Activates guanylyl cyclase → cGMP → activates PKG → promotes Ca2+ efflux and activates MLCP → vasodilation
- Stretch (myogenic response): stretch → depolarization → Ca2+ entry → contraction (important in autoregulation)
Guyton & Hall Textbook of Medical Physiology, p. 113
Campbell-Walsh-Wein Urology

17. CLINICALLY IMPORTANT PATHOPHYSIOLOGY

Condition	Mechanism	Key Feature
Duchenne MD	Dystrophin gene deletion (X-linked recessive)	No dystrophin → membrane instability, Ca2+ leak, proteolysis; wheelchair by age 12, death by ~30
Becker MD	Partial dystrophin mutation	Milder, later onset
Malignant hyperthermia	RyR1 mutation → uncontrolled Ca2+ release triggered by volatile anesthetics/succinylcholine	Hyperthermia, rigidity, rhabdomyolysis; treat with dantrolene (RyR1 blocker)
Hypokalemia	Low ECF K+ → hyperpolarization of muscle → difficult to reach threshold	Muscle weakness
Hyperkalemia	High ECF K+ → depolarization → inactivation of Na+ channels	Muscle weakness and paralysis
Myasthenia gravis	IgG anti-nAChR antibodies	NMJ failure; tx with anticholinesterases (pyridostigmine), immunosuppression
Lambert-Eaton	Anti-VGCC (presynaptic) antibodies	Improves with repeated stimulation
Rigor mortis	ATP depletion → permanent cross-bridge formation	Resolves in 15-25 hours by proteolysis
Rhabdomyolysis	Massive muscle injury → myoglobin release → acute kidney injury	CK markedly elevated

PART 4 - 50 HIGH-YIELD, DIFFICULT, AND CONCEPTUAL MCQs

SECTION A: STRUCTURAL AND MOLECULAR (Q1-12)

Q1. During maximal isometric contraction of skeletal muscle at optimal sarcomere length, which band or zone does NOT change in width?

A) I band
B) H zone
C) A band ✅
D) Distance between Z disks
E) Distance between M lines and Z disks

Explanation: The A band is defined by the full length of myosin thick filaments. The thick filaments themselves do not shorten; only the thin filaments slide inward. The I band (actin only), H zone (myosin only), and Z-disk distance all decrease. The A band is constant.

Q2. A researcher disrupts the titin protein selectively in a muscle fiber. Which of the following would be the FIRST consequence?

A) Failure of Ca2+ release from SR
B) Loss of passive tension at long muscle lengths and sarcomere instability at short lengths ✅
C) Inability to phosphorylate myosin light chains
D) Loss of tropomyosin anchorage to actin
E) Failure of DHPR-RyR coupling

Explanation: Titin is the elastic "spring" anchoring myosin to the Z disk. It provides passive tension when stretched and prevents over-compression. Disrupting it would destabilize sarcomere geometry and abolish passive tension - not E-C coupling per se.

Q3. Tropomyosin physically occupies the myosin-binding groove on actin in relaxed muscle. What is the stoichiometric relationship between the troponin complex and actin monomers?

A) 1 troponin per actin monomer
B) 1 troponin per 3 actin monomers
C) 1 troponin per 7 actin monomers ✅
D) 1 troponin per 14 actin monomers
E) 1 troponin per tropomyosin unit (which covers 3 actin monomers)

Explanation: One tropomyosin molecule spans 7 actin monomers along the helix, and one troponin complex is attached to each tropomyosin, giving a 1:7 troponin:actin ratio.

Q4. In the cross-bridge cycle, which event is the DIRECT trigger for the power stroke?

A) ATP binding to myosin head
B) ADP release from myosin head
C) Pi (inorganic phosphate) release from myosin head ✅
D) Ca2+ binding to troponin C
E) Myosin head detachment from actin

Explanation: ATP is hydrolyzed to ADP + Pi during the cocking step. The power stroke is initiated by Pi release (which releases stored energy), while ADP release follows the stroke and reinforces strong binding. ATP binding causes detachment.

Q5. Why does rigor mortis resolve spontaneously 15-25 hours after death without any external intervention?

A) Restoration of ATP via anaerobic glycolysis
B) Passive diffusion of Ca2+ back into SR
C) Autolysis of myosin and actin by lysosomal proteases ✅
D) Depletion of myosin ATPase activity
E) Na+/K+ ATPase-mediated membrane repolarization

Explanation: Rigor mortis is maintained by absence of ATP (cross-bridges cannot detach). Resolution is NOT due to ATP regeneration but to structural degradation of contractile proteins by lysosomal enzymes released during autolysis. Higher temperatures accelerate this process.

Q6. A protein in the thick filament is described as having "side-polar cross-bridge arrangement where bridges on one side hinge in the opposite direction from the other side." In which muscle type is this found and what is its functional significance?

A) Skeletal; allows rapid cycling
B) Cardiac; allows CICR
C) Smooth muscle; allows ~80% shortening of resting length ✅
D) Skeletal; maintains A-band constancy
E) Cardiac; provides the Frank-Starling response

Explanation: Smooth muscle myosin has side-polar filaments (unlike the bipolar arrangement in striated muscle). This geometry allows simultaneous pulling of actin in both directions, enabling much greater degrees of shortening than skeletal muscle's < 30%.

Q7. Which component of the troponin complex directly binds calcium ions to initiate contraction?

A) Troponin I
B) Troponin T
C) Troponin C ✅
D) Tropomyosin
E) Calmodulin (in skeletal muscle)

Explanation: Troponin C (TnC) is the Ca2+-binding subunit (structurally similar to calmodulin). TnI is inhibitory (binds actin to block cross-bridge). TnT anchors the complex to tropomyosin.

Q8. Cardiac muscle T tubules have a volume 25x greater than skeletal muscle T tubules. What is the PRIMARY functional consequence of this difference?

A) Faster action potential propagation
B) Greater Ca2+ storage in SR terminal cisternae
C) Abundant luminal mucopolysaccharides store extracellular Ca2+ available for CICR ✅
D) Reduced refractory period
E) Enhanced DHPR-RyR1 mechanical coupling

Explanation: The wide cardiac T tubules contain mucopolysaccharides that bind Ca2+ from extracellular fluid. This Ca2+ is the "trigger Ca2+" for CICR. Cardiac muscle depends on extracellular Ca2+ for each contraction, unlike skeletal muscle.

Q9. A mutation specifically impairs the ability of dihydropyridine receptors (DHPRs) to mechanically couple with ryanodine receptors (RyR1) but leaves the DHPR's Ca2+ channel function intact. In which tissue would this cause the most severe physiological dysfunction?

A) Cardiac muscle (stops beating)
B) Smooth muscle (loses tone)
C) Skeletal muscle (cannot contract despite intact action potentials) ✅
D) Both cardiac and skeletal equally
E) No effect because DHPR Ca2+ channel is still intact

Explanation: In skeletal muscle, DHPR acts purely as a voltage sensor, mechanically (not via Ca2+ current) triggering RyR1. Loss of this mechanical coupling abolishes E-C coupling in skeletal muscle. Cardiac muscle uses DHPR as a Ca2+ channel for CICR, so preserved Ca2+ channel function would still allow cardiac contraction.

Q10. In a muscle biopsy stained for mATPase at pH 9.4, Type I fibers appear PALE and Type II fibers appear DARK. If the same biopsy is stained at pH 4.3, what would be expected?

A) Type I = pale, Type II = dark (same result)
B) Type I = dark, Type II = pale ✅
C) Both types appear dark
D) Only Type IIA stains; IIB is unstained
E) No staining because mATPase is denatured at pH 4.3

Explanation: mATPase staining is pH-dependent. At alkaline pH (9.4): Type II = dark. At acid pH (4.3): Type I = dark (because Type I mATPase is alkali-labile but acid-stable). This reversal is the key to differentiating fiber types histologically.

Q11. In the Huxley sliding filament model, the thin filaments from each side of a sarcomere begin to overlap with each other (anti-parallel overlap of thin filaments) when sarcomere length is reduced below a critical value. What direct consequence would this have on force generation?

A) Increased force due to double contribution
B) Decreased force because anti-parallel actin-actin interactions sterically hinder myosin cross-bridges ✅
C) No effect since cross-bridges only interact with the near-side actin
D) Increased passive tension only
E) Complete abolition of contraction since actin is neutralized

Explanation: Below ~2.0 µm sarcomere length, thin filaments from opposite Z disks overlap, creating steric interference with cross-bridge cycling. This reduces active force generation (part of the descending limb of the length-tension curve at very short lengths).

Q12. Dystrophin links actin to the dystrophin-associated protein complex (DAPC) at the sarcolemma. In Duchenne MD, the absence of dystrophin primarily causes dysfunction via which mechanism?

A) Failure to phosphorylate myosin light chains
B) Impaired SERCA pump activity
C) Sarcolemmal instability with increased membrane Ca2+ permeability → intracellular Ca2+ overload → proteolysis ✅
D) Loss of RyR1 anchoring to SR
E) Reduced satellite cell proliferation

Explanation: Without dystrophin, the mechanical link between the cytoskeleton and extracellular matrix is broken. Membrane damage during contraction allows abnormal Ca2+ entry, triggering protease activation and cell death. This is the primary pathomechanism.

SECTION B: NEUROMUSCULAR JUNCTION (Q13-20)

Q13. Lambert-Eaton Myasthenic Syndrome (LEMS) is caused by antibodies against presynaptic voltage-gated Ca2+ channels. Why does muscle strength PARADOXICALLY IMPROVE with repetitive stimulation, opposite to myasthenia gravis?

A) Upregulation of postsynaptic nAChRs with use
B) Each action potential causes more Ca2+ influx; repetitive firing causes Ca2+ accumulation in presynaptic terminal, progressively increasing ACh release ✅
C) Antibody neutralization by repeated antigen exposure
D) Postsynaptic receptor sensitization
E) Cross-reacting antibodies are depleted

Explanation: In LEMS, each stimulus releases fewer vesicles (fewer active zone Ca2+ channels). But with repeated stimulation, residual Ca2+ accumulates in the presynaptic terminal (facilitation), increasing vesicle fusion and ACh release - hence paradoxical improvement. In MG, postsynaptic receptors are the target; repetition exhausts the limited ACh binding capacity.

Q14. Botulinum toxin type A cleaves SNAP-25. Botulinum toxin type B cleaves synaptobrevin (VAMP). What is the common final result and why does it take weeks to months to wear off?

A) Destruction of the motor end plate; wears off as new plates grow
B) Inhibition of SNARE complex formation → blocked ACh exocytosis; recovery awaits axonal sprouting and new NMJ formation ✅
C) Irreversible ACh receptor blockade
D) Irreversible inhibition of acetylcholinesterase
E) Myosin head denaturation

Explanation: SNARE proteins (SNAP-25, synaptobrevin, syntaxin) are required for synaptic vesicle fusion with the presynaptic membrane. Their proteolytic cleavage permanently prevents vesicle fusion in that terminal. Recovery requires growth of new axonal sprouts to form new functional NMJs - a process taking weeks to months.

Q15. A patient is given a non-depolarizing neuromuscular blocker (e.g., vecuronium) and then neostigmine to reverse it. Which of the following explains why neostigmine reverses vecuronium?

A) Neostigmine directly displaces vecuronium from nAChRs
B) Neostigmine inhibits acetylcholinesterase → ACh accumulates → outcompetes vecuronium at nAChR (competitive antagonism reversal) ✅
C) Neostigmine stimulates ACh synthesis
D) Neostigmine activates muscarinic receptors to increase ACh release
E) Neostigmine binds vecuronium directly

Explanation: Non-depolarizing blockers compete with ACh at the nAChR. Neostigmine prevents ACh degradation, raising ACh concentration at the synapse, which mass-action-drives ACh to outcompete and displace the blocker from the receptor.

Q16. Succinylcholine is a depolarizing neuromuscular blocker. It initially causes fasciculations followed by flaccid paralysis. What is the mechanism of the flaccid paralysis phase?

A) Desensitization (phase II block): prolonged receptor activation inactivates the nAChR and surrounding voltage-gated Na+ channels → sustained depolarization prevents repolarization needed for action potential initiation ✅
B) Competitive blockade of nAChRs
C) Presynaptic inhibition of ACh release
D) Inhibition of Ca2+ release from SR
E) K+ influx hyperpolarizes membrane

Explanation: Succinylcholine is not hydrolyzed by acetylcholinesterase (only by plasma pseudocholinesterase, slowly). Sustained receptor activation (phase I = depolarization block) eventually leads to phase II = desensitization block, where the receptor enters a refractory state. The initial fasciculations are from the early depolarization wave; then flaccid paralysis follows.

Q17. In organophosphate poisoning (irreversible acetylcholinesterase inhibitor), why does skeletal muscle initially show fasciculations and then progress to flaccid paralysis (not tetanic spasm)?

A) ACh overstimulates nAChRs → initial depolarization (fasciculations) → sustained depolarization → phase II depolarization block → flaccid paralysis ✅
B) Muscarinic receptors at NMJ are activated causing inhibition
C) Presynaptic inhibition of ACh release
D) Direct muscle membrane stabilization
E) Ca2+ channel blockade

Explanation: Same mechanism as succinylcholine overdose at the NMJ. nAChRs are nicotinic (ionotropic), not muscarinic. Excess ACh causes the same depolarization block sequence. (The smooth muscle and secretory effects from muscarinic overstimulation are separate.)

Q18. The "safety factor" of the NMJ means the EPP is approximately 3x the threshold for action potential generation. In myasthenia gravis, the safety factor is reduced because fewer functional nAChRs are present. At what point does clinical weakness first become apparent?

A) When the EPP is reduced below 50% of threshold
B) When the EPP is reduced but still above threshold (reserve is consumed, but EPP still suprathreshold with normal stimulation; weakness appears when safety factor falls below 1.0) ✅
C) Immediately when any antibody is detected
D) When ACh synthesis fails
E) When acetylcholinesterase activity falls below 50%

Explanation: Clinical weakness appears only when the EPP can no longer reliably reach threshold - i.e., when the safety margin is exhausted. The safety factor can be reduced significantly before weakness appears, explaining the gradual onset. High-frequency stimulation reveals the deficit earlier (decremental response on nerve conduction studies).

Q19. Why does malignant hyperthermia occur specifically with volatile halogenated anesthetics (e.g., sevoflurane) and succinylcholine but NOT with propofol or opioids?

A) Propofol has anticholinergic properties
B) Volatile agents and succinylcholine trigger abnormal RyR1 opening in genetically susceptible individuals → uncontrolled SR Ca2+ release → hypermetabolic crisis; propofol does not activate RyR1 ✅
C) Succinylcholine depletes magnesium, which normally blocks RyR
D) Volatile anesthetics inhibit SERCA pump
E) Propofol activates MLCK preventing Ca2+ overload

Explanation: MH is caused by gain-of-function mutations in RyR1. Volatile agents and succinylcholine act as triggers for pathological RyR1 opening. Propofol acts via GABA-A/Kv channels, not RyR1. Treatment: dantrolene (directly blocks RyR1), active cooling, bicarbonate.

Q20. A patient with chronic MG is started on pyridostigmine. Later they develop a cholinergic crisis. How do you differentiate a cholinergic crisis from a myasthenic crisis clinically, and what is the pharmacological test?

A) Edrophonium (Tensilon) test: improves myasthenic crisis (more ACh helps), worsens or no change in cholinergic crisis ✅
B) Atropine test: blocks muscarinic receptors, resolves both crises
C) Neostigmine test: worsens myasthenic crisis
D) Edrophonium worsens myasthenic crisis
E) Blood ACh levels differentiate them

Explanation: Myasthenic crisis = insufficient ACh activity at NMJ (more anti-ACh drug would help temporarily). Cholinergic crisis = too much ACh from overdose of pyridostigmine (more anti-ACh drug worsens it). The Tensilon test (short-acting anticholinesterase) gives transient improvement in MG but no improvement/worsening in cholinergic crisis.

SECTION C: E-C COUPLING AND CONTRACTION MECHANICS (Q21-32)

Q21. In cardiac muscle, the force of contraction is said to be proportional to intracellular [Ca2+]. A positive inotropic drug (e.g., digoxin) increases force WITHOUT directly affecting the action potential. What is the most likely mechanism?

A) Direct RyR2 activation
B) Na+/K+ ATPase inhibition → Na+ accumulates intracellularly → NCX (Na+/Ca2+ exchanger) reverses or slows → Ca2+ accumulates intracellularly → increased SR Ca2+ load → more Ca2+ released per beat ✅
C) Phosphodiesterase inhibition
D) Direct SERCA activation
E) Increased L-type Ca2+ channel density

Explanation: Digoxin inhibits Na+/K+ ATPase → intracellular [Na+] rises → NCX (normally 3Na+ in, 1Ca2+ out) becomes less efficient at extruding Ca2+ → intracellular Ca2+ rises gradually → SR stores more Ca2+ → stronger CICR. This is the classic digoxin mechanism.

Q22. During the cardiac action potential plateau (Phase 2), the slow inward Ca2+ current flows through L-type Ca2+ channels. Why does the plateau phase NOT cause tetanus in cardiac muscle (unlike skeletal muscle)?

A) Cardiac myosin has lower ATPase activity
B) The absolute refractory period of cardiac muscle lasts almost as long as the contraction itself, making re-excitation impossible until relaxation is nearly complete ✅
C) The SR releases less Ca2+ per beat
D) Cardiac troponin has lower Ca2+ affinity
E) Gap junctions dilute the action potential

Explanation: The cardiac action potential lasts ~200-400 ms (vs. 1-2 ms for skeletal muscle), and the absolute refractory period extends throughout most of the plateau and early repolarization. The muscle cannot be re-stimulated until it has substantially relaxed. This prevents tetanus - essential for the heart's pumping function (a tetanic heart could not refill).

Q23. A skeletal muscle is stimulated at a frequency just below the tetanic fusion frequency. Tension is sustained but shows slight oscillation. What is this state called, and what change in [Ca2+]i is occurring?

A) Twitch summation; Ca2+ falls completely between stimuli
B) Incomplete tetanus; Ca2+ rises with each stimulus but does not fully fall between stimuli - resting Ca2+ is elevated above threshold ✅
C) Complete tetanus; Ca2+ is at maximum continuously
D) Post-tetanic potentiation; Ca2+ is supramaximal
E) Fatigue; Ca2+ release per stimulus is declining

Explanation: In incomplete (unfused) tetanus, the stimulation frequency is fast enough that each new Ca2+ release adds to the residual Ca2+ before it has been fully reuptaken, maintaining Ca2+ above the troponin C binding threshold between stimuli. There is some oscillation because Ca2+ fluctuates slightly.

Q24. A muscle fiber is stretched beyond 3.6 µm sarcomere length. What is the predicted active tension and what is the dominant source of any remaining tension at this length?

A) Active tension = maximum; passive = negligible
B) Active tension = zero (no actin-myosin overlap); remaining tension = passive (from titin and connective tissue) ✅
C) Active tension = zero; no passive tension at this length
D) Active tension = 50%; passive tension additive
E) Active tension increases due to titin acting as additional cross-bridges

Explanation: Beyond ~3.6 µm, there is no overlap between thick and thin filaments, so no cross-bridges can form and active tension = zero. Total tension at this length is entirely passive, arising from titin extensibility and connective tissue stretch. This is the plateau region of the passive tension curve.

Q25. Why does eccentric contraction (muscle lengthening under load) generate GREATER force than maximal isometric contraction?

A) More Ca2+ is released from SR during eccentric loading
B) Additional passive forces (titin engagement, connective tissue stretch) contribute to force; cross-bridges are also held in strong-binding state longer under resisting load; and "winding" of titin on the actin helix adds to cross-bridge force ✅
C) More ATP is available during eccentric work
D) Tropomyosin is displaced further during stretch
E) More fibers are recruited by the motor cortex

Explanation: During eccentric contraction, the combination of active cross-bridge force resisting elongation PLUS passive elastic forces (titin, actin-titin interaction) produces total force exceeding isometric P0. Recent research (PMID 37290181) emphasizes titin's role in amplifying force during active stretching (referred to as residual force enhancement).

Q26. Phosphocreatine (PCr) is the first energy buffer used during intense exercise. At the start of maximal sprint exercise, the PCr system delays lactate production for approximately how long, and what enzyme catalyzes this reaction?

A) ~30 seconds; phosphofructokinase
B) ~8-10 seconds of maximal effort; creatine kinase ✅
C) ~2 minutes; lactate dehydrogenase
D) ~20 seconds; adenylate kinase
E) ~1 minute; ATP synthase

Explanation: PCr stores are limited, providing immediate ATP for approximately 8-10 seconds of maximal effort. Creatine kinase catalyzes: PCr + ADP → Creatine + ATP. This is why sprint events under ~10 seconds are primarily PCr-powered.

Q27. SERCA pump efficiency in SR Ca2+ reuptake consumes ATP. Which drug directly inhibits SERCA, and what is the physiological consequence in a diseased muscle cell?

A) Ryanodine; impaired relaxation
B) Thapsigargin (experimental); impaired SR Ca2+ reuptake → elevated [Ca2+]i → impaired relaxation and Ca2+ overload ✅
C) Dantrolene; impaired SR Ca2+ release
D) Verapamil; impaired L-type channel function
E) Cyclosporine; impaired mitochondrial Ca2+ buffering

Explanation: Thapsigargin is a potent, irreversible SERCA inhibitor used in research. Impaired SERCA (also seen in heart failure with SERCA2a downregulation) leads to [Ca2+]i elevation, impaired relaxation (lusitropy), and eventually Ca2+ overload with activation of proteases and apoptosis.

Q28. Phospholamban (PLN) is a small inhibitory protein that, in its unphosphorylated state, inhibits SERCA in the cardiac SR. β1-adrenergic receptor stimulation (e.g., from adrenaline) phosphorylates PLN. What are the two combined effects?

A) Decreased contractility and decreased heart rate
B) Increased SR Ca2+ uptake (faster relaxation = improved lusitropy) + increased SR Ca2+ load (more Ca2+ per beat = increased inotropy) ✅
C) Increased heart rate only
D) Decreased SR Ca2+ release
E) DHPR activation

Explanation: β1 stimulation → PKA → phosphorylates PLN → PLN releases its inhibition of SERCA → SERCA works faster → Ca2+ cleared faster from cytoplasm → (1) faster relaxation (lusitropic effect), (2) more Ca2+ stored in SR → more Ca2+ released per subsequent beat (positive inotropic effect). This is the molecular basis of sympathetic cardiac stimulation.

Q29. "Residual force enhancement" is a poorly understood but experimentally proven phenomenon: after an eccentric contraction, muscles produce more force than predicted by the force-length curve at that new longer length. Which protein is most strongly implicated in current research?

A) Actin (new cross-bridges formed)
B) Tropomyosin (altered position)
C) Titin (passive force enhanced by Ca2+-dependent titin stiffening and actin-titin engagement) ✅
D) Desmin
E) Myosin binding protein C

Explanation: Recent biomechanical and cryo-EM evidence (PMID 37290181) implicates titin as the main contributor to residual force enhancement. During active stretching, titin stiffens in a Ca2+-dependent manner and may engage with the thin filament, producing force above the pure actomyosin prediction.

Q30. The Hill equation for muscle contraction states: (P + a)(V + b) = (P0 + a)b. Which parameter is directly determined by myosin ATPase activity and distinguishes Type I from Type II fibers most clearly?

A) P0 (maximum isometric force)
B) Vmax (maximum shortening velocity, extrapolated at zero load) ✅
C) a (force constant)
D) b (velocity constant)
E) (P0 + a)b (power constant)

Explanation: Vmax (the y-intercept when load = 0) represents how fast cross-bridges cycle when unloaded, which is directly determined by myosin ATPase rate. Type II fibers have high ATPase → high Vmax. P0 depends on cross-sectional area and number of cross-bridges, not ATPase rate per se.

Q31. A muscle at rest has a sarcoplasmic [Ca2+] of ~10-7 M. During maximal activation, it rises to ~10-5 M. Troponin C's dissociation constant (Kd) for Ca2+ is ~10-6 M. What fraction of TnC sites would be occupied at rest and at activation?

A) Rest = 0%, Activation = 100%
B) Rest ~10% (below Kd), Activation ~90%+ (well above Kd) ✅
C) Rest = 50%, Activation = 100%
D) Rest = 0.1%, Activation = 50%
E) Rest = 5%, Activation = 100%

Explanation: Using the receptor occupancy concept, at 10x below Kd (rest), occupancy ≈ 10/(10+100) ≈ ~9%. At 10x above Kd (activation, ~10-5 M), occupancy ≈ 1000/(1000+100) = ~91%. This demonstrates why resting muscle does not contract despite containing troponin, and why activation is nearly complete during a strong twitch.

Q32. In smooth muscle, inhibition of Rho kinase (ROCK) would be expected to cause what effect?

A) Vasoconstriction due to increased Ca2+ sensitivity
B) Vasodilation by allowing myosin phosphatase to dephosphorylate myosin, reducing tone even at existing Ca2+ levels ✅
C) Increased PKC activity
D) SR Ca2+ depletion
E) Calmodulin sequestration

Explanation: ROCK inhibits myosin light-chain phosphatase (MLCP). When ROCK is inhibited, MLCP is disinhibited and dephosphorylates myosin → relaxation. Rho/ROCK pathway is responsible for Ca2+ sensitization (maintaining tone without Ca2+ elevation). ROCK inhibitors (e.g., fasudil) are used in pulmonary arterial hypertension.

SECTION D: FIBER TYPES, METABOLISM, FATIGUE (Q33-40)

Q33. In a marathon runner, their postmortem quadriceps biopsy shows a checkerboard pattern with predominantly dark fibers on acid-pH mATPase staining. What can be concluded?

A) Predominantly fast-twitch (Type II) fibers
B) Predominantly slow-twitch (Type I) fibers, consistent with endurance athlete profile ✅
C) Predominantly Type IIC transitional fibers
D) Predominantly glycolytic fibers
E) Abnormal - athletes should have all type II

Explanation: At acid pH (4.3), Type I fibers stain dark (acid-stable mATPase). Marathon runners have predominantly Type I (slow-twitch, oxidative, fatigue-resistant) fibers. Sprinters would show the opposite pattern.

Q34. Why does caffeine enhance athletic performance at the cellular level in skeletal muscle?

A) Increases ACh release at NMJ
B) Directly opens RyR1/RyR2 → increased Ca2+ release from SR → enhanced cross-bridge activation ✅
C) Inhibits phosphodiesterase only in smooth muscle
D) Upregulates SERCA pump activity
E) Increases glycogen synthase activity

Explanation: At physiological concentrations in muscle, caffeine sensitizes ryanodine receptors (lowers their threshold for opening) → more Ca2+ per AP → greater cross-bridge activation → increased force production. At toxic doses (very high), it can cause uncontrolled Ca2+ release.

Q35. With progressive recruitment during exercise, which of the following sequences correctly follows the Henneman Size Principle (Orderly Recruitment)?

A) Type IIB → Type IIA → Type I
B) Type I (small motor units, low threshold) → Type IIA → Type IIB (large motor units, high threshold) ✅
C) Type IIA → Type I → Type IIB
D) Random recruitment based on task
E) Only Type II units are recruited during power tasks

Explanation: Small motor neurons innervating Type I (slow, oxidative) fibers have the lowest input resistance and are most easily excited (lowest current required to reach threshold). This "size principle" ensures metabolically economical, fatigue-resistant fibers are used first, with power fibers recruited only when needed.

Q36. After 2-3 weeks of complete bed rest, which of the following changes in muscle physiology is most predictable?

A) Selective atrophy of Type I fibers with preservation of Type II
B) Preferential atrophy of Type II fibers with shift toward Type I phenotype, plus loss of total muscle cross-sectional area ✅
C) Increase in PCr stores to compensate
D) Upregulation of SERCA pump
E) Increased mATPase activity

Explanation: Disuse atrophy predominantly affects Type II (fast, glycolytic) fibers, though all fibers reduce in size. There is a phenotypic shift toward slower, oxidative fibers with disuse. This is opposite to training adaptations.

Q37. Pi (inorganic phosphate) accumulation during intense exercise contributes to fatigue. What is the specific mechanism at the cross-bridge level?

A) Pi directly blocks troponin C Ca2+ binding
B) Pi rebinds to myosin heads after premature release, slowing the rate of Pi release step and thereby slowing the power stroke transition, reducing force ✅
C) Pi acidifies the SR, blocking Ca2+ release
D) Pi chelates Ca2+ in sarcoplasm
E) Pi stimulates MLCK in skeletal muscle

Explanation: The power stroke is triggered by Pi release. High Pi concentrations (from ATPase activity) favor reversal of this step (Pi rebinds prematurely), reducing the fraction of cross-bridges in the high-force state and slowing force development per cycle.

Q38. A sprinter runs 100 m in ~10 seconds. During the race, which energy systems contribute and in what order?

A) Oxidative → Glycolytic → PCr
B) PCr (primary, first 8-10s) → Anaerobic glycolysis (kick in by ~5s, dominant 10-30s) → Oxidative (minimal at this duration) ✅
C) Oxidative → PCr → Glycolytic
D) All three contribute equally throughout
E) Only PCr for entire sprint

Explanation: PCr provides immediate power for the first 8-10 seconds. Glycolysis begins within the first few seconds but takes a few seconds to fully accelerate. Oxidative phosphorylation requires ~2-3 minutes to reach full activity and contributes minimally in a 10-second sprint. In a 400 m race (~45 seconds), anaerobic glycolysis dominates.

Q39. Why can type I slow-twitch muscle fibers sustain activity for hours while type IIB fast-twitch fibers fatigue in seconds, despite both using ATP?

A) Type I has more myosin per sarcomere
B) Type I has much higher mitochondrial density, relies on oxidative phosphorylation (large ATP yield), and has high myoglobin (O2 storage); Type IIB relies on anaerobic glycolysis with PCr, producing limited ATP and accumulating fatigue metabolites quickly ✅
C) Type I has lower mATPase, meaning it uses less ATP per contraction
D) Both A and C
E) Type I has slower twitch but higher cross-bridge density

Explanation: The combination of: (1) aerobic metabolism (near-unlimited substrate), (2) high mitochondrial density, (3) high myoglobin content (O2 buffering), and (4) lower intrinsic power demands (lower mATPase, slower cycling) make Type I fibers extremely fatigue-resistant. Low mATPase (C) is also correct and contributes, so D is arguable, but the primary answer is B + C.

Q40. What is the "latch state" in smooth muscle and what is its physiological advantage?

A) Complete relaxation with Ca2+ removal
B) A state where slowly cycling (or non-cycling) phosphorylated cross-bridges maintain force at very low ATP consumption - allows sustained vascular tone at minimal energy cost ✅
C) A pathological state seen in smooth muscle spasm
D) Maximum velocity contraction with phosphorylated myosin
E) Ca2+-independent contraction via PKC

Explanation: In the latch state, smooth muscle maintains tension with minimal ATP consumption. Cross-bridges become "latched" (dephosphorylated but not detached) - they cycle very slowly or not at all but maintain force. This is ideal for tonic vascular smooth muscle maintaining constant blood pressure.

SECTION E: CLINICAL/PATHOPHYSIOLOGY (Q41-50)

Q41. A 28-year-old male athlete develops severe muscle pain, dark urine, and acute kidney injury after an extreme endurance event. Serum CK is 50,000 IU/L (normal < 200). What is the mechanism of AKI?

A) Direct renal tubular toxicity of lactate
B) Myoglobin released from necrotic muscle precipitates in renal tubules (especially in acidic urine) → tubular obstruction + direct tubular toxicity → AKI ✅
C) Hemoglobin from hemolysis clogs tubules
D) Dehydration → prerenal AKI only
E) Inflammatory cytokines damage glomeruli

Explanation: Rhabdomyolysis releases myoglobin from damaged muscles. Unlike hemoglobin, myoglobin's smaller size means it passes freely through the glomerulus. In acidic, concentrated urine, it forms casts that obstruct tubules and exerts direct ferryl-mediated oxidative toxicity. Treatment: aggressive IV fluid hydration to alkalinize urine and dilute myoglobin.

Q42. In Duchenne MD, why is serum CK markedly elevated BEFORE clinical weakness appears?

A) CK is synthesized in excess in early disease
B) Membrane instability (from absent dystrophin) causes continuous microscopic membrane leakage of CK from muscle cells even before significant fiber necrosis ✅
C) Liver CK (CK-2) is released early
D) Regenerating satellite cells release CK
E) Inflammatory infiltrate releases CK

Explanation: The dystrophin-deficient sarcolemma is mechanically fragile. During normal daily contractions, micro-tears allow CK (normally confined to the cytoplasm) to leak into the bloodstream - even when fibers are not yet necrotic. This is why CK is the earliest biochemical marker of DMD, detectable in the neonatal period.

Q43. Hyperkalemia causes muscle weakness through what mechanism, and why does severe hyperkalemia paradoxically cause flaccid paralysis rather than tetanic spasm?

A) K+ inhibits ACh release at NMJ
B) High ECF [K+] reduces the resting membrane potential (less negative), causing sustained partial depolarization → inactivation of voltage-gated Na+ channels (Na+ channels inactivate and cannot recover at depolarized potentials) → muscle cannot generate action potentials → flaccid paralysis ✅
C) K+ competes with Ca2+ at troponin C
D) K+ inhibits SERCA pump
E) K+ blockade of acetylcholine receptors

Explanation: The resting membrane potential is determined largely by K+ equilibrium. High extracellular [K+] depolarizes the membrane. While mild hyperkalemia causes increased excitability, severe hyperkalemia depolarizes so extensively that voltage-gated Na+ channels cannot recover from inactivation (they require repolarization to recover). The membrane cannot fire action potentials → flaccid weakness. This explains why reference book box (Costanzo, p. 893): "Clinical Physiology: Hyperkalemia With Muscle Weakness."

Q44. A patient with hypothyroidism complains of muscle stiffness and delayed relaxation after voluntary contraction (pseudomyotonia). Why does hypothyroidism cause this?

A) Increased myosin ATPase due to thyroid hormone
B) Decreased SERCA pump expression → slow Ca2+ reuptake into SR → delayed relaxation ✅
C) Increased acetylcholinesterase activity
D) Upregulation of RyR1
E) Shift to Type II fiber predominance

Explanation: Thyroid hormone (T3) transcriptionally upregulates SERCA expression, as well as fast myosin isoforms. In hypothyroidism, SERCA is downregulated → Ca2+ clearance from sarcoplasm is delayed → slow relaxation (pseudomyotonia). This is distinct from true myotonia (Na+/Cl- channel mutations), which is electrically mediated.

Q45. In cardiac heart failure, SERCA2a activity is reduced by ~30%. What are the dual hemodynamic consequences?

A) Tachycardia only
B) Impaired relaxation (diastolic dysfunction - reduced ventricular filling) + reduced SR Ca2+ load (systolic dysfunction - less Ca2+ per beat, reduced contractility) ✅
C) Purely systolic dysfunction
D) Purely diastolic dysfunction
E) Increased contractility to compensate

Explanation: SERCA2a downregulation has dual effects: (1) Cytoplasmic Ca2+ clears more slowly → impaired diastolic relaxation → diastolic dysfunction. (2) Less Ca2+ stored in SR → less Ca2+ released per beat → reduced contractile force → systolic dysfunction. This is why targeting SERCA2a (via SERCA2a gene therapy - AAV-SERCA2a - is an active area of clinical research).

Q46. Dantrolene treats malignant hyperthermia. It also treats spasticity. What is the mechanism and why does it NOT cause fatal cardiac arrest despite affecting cardiac RyR?

A) Dantrolene blocks L-type Ca2+ channels in both tissues
B) Dantrolene blocks RyR1 (skeletal) >> RyR2 (cardiac); cardiac muscle also depends on extracellular Ca2+ entry through L-type channels for CICR, so partial RyR2 blockade is tolerated ✅
C) Dantrolene activates MLCP in smooth muscle
D) Dantrolene has no cardiac effect
E) Dantrolene competitively inhibits calmodulin

Explanation: Dantrolene has much higher affinity for RyR1 (skeletal) than RyR2 (cardiac). Furthermore, cardiac contraction depends critically on the L-type Ca2+ trigger current, not just on RyR. The lesser RyR2 blockade combined with preserved trigger Ca2+ entry means cardiac function is maintained at therapeutic doses. This selectivity is fortunate and is exploited clinically.

Q47. During sustained isometric contraction of the hand gripping a heavy object for > 60 seconds, blood flow to the muscle is occluded by the high intramuscular pressure. What energy system must the muscle rely on and what limits performance?

A) Oxidative phosphorylation, limited by mitochondrial enzyme kinetics
B) Anaerobic glycolysis and PCr, limited by lactate/H+ accumulation and PCr depletion ✅
C) PCr only for 60+ seconds
D) Oxidative only, limited by myoglobin oxygen stores
E) Glycogen synthesis limits performance

Explanation: Intramuscular pressure exceeding ~60-70 mmHg occludes perfusing capillaries. The muscle becomes ischemic - must rely on anaerobic systems (PCr for the first ~8-10s, then glycolysis). Accumulation of H+, Pi, and lactate (and local K+ elevation) causes fatigue and eventually forces relaxation.

Q48. In a Type I slow-twitch fiber expressing exclusively MHC-I isoform, what would be the expected change if the motor nerve innervating it were cross-reinnervated to supply it with a fast motor neuron (previously innervating Type IIB fibers)?

A) No change, fiber type is permanently genetically determined
B) The fiber would gradually transform toward a Type II phenotype (MHC switch to IIA/IIB, increased mATPase, reduced mitochondria) driven by altered neural activity patterns ✅
C) Immediate switch to Type II
D) Fiber undergoes apoptosis
E) Fiber retains Type I but gains fast motor neuron properties

Explanation: This cross-reinnervation experiment (classic Buller, Eccles & Eccles, 1960) demonstrated that fiber type is determined by motor neuron activity patterns, not purely by genetics. High-frequency neural signals from fast motor neurons transform slow fibers toward fast phenotype over weeks. This also underpins training adaptations (endurance → more Type I; high-intensity → more IIA).

Q49. Nitric oxide (NO) causes smooth muscle relaxation. A patient with heart failure is given an NO donor drug (isosorbide dinitrate). Trace the complete signaling pathway from NO to smooth muscle relaxation.

A) NO → cAMP → PKA → phospho-MLCK → reduced myosin phosphorylation → relaxation
B) NO → soluble guanylyl cyclase (sGC) → cGMP → protein kinase G (PKG) → phosphorylates and inhibits MLCK + activates MLCP → reduced myosin phosphorylation → relaxation; ALSO PKG promotes Ca2+ efflux via sarcolemmal Ca2+ ATPase ✅
C) NO → Ca2+ channel blockade directly
D) NO → muscarinic receptor activation
E) NO → calmodulin sequestration

Explanation: This is the canonical NO-cGMP-PKG relaxation pathway. PKG has multiple targets: inhibitory phosphorylation of MLCK (reduces its activity), activation of MLCP (increases dephosphorylation of myosin), opening of K+ channels (hyperpolarization → reduced Ca2+ entry), and stimulation of Ca2+ pumps.

Q50. A researcher creates a transgenic mouse in which the troponin I (TnI) phosphorylation sites (serine residues targeted by PKA) are mutated to alanine (cannot be phosphorylated). The mouse is given high-dose dobutamine (β1 agonist). Compared to a wild-type mouse, what specific cardiac property would be most impaired in the transgenic mouse?

A) Positive inotropy (increased contractile force)
B) Positive chronotropy (increased heart rate)
C) Positive lusitropy (accelerated relaxation) ✅ - because PKA-mediated TnI phosphorylation normally reduces Ca2+ affinity of TnC → faster Ca2+ dissociation → faster cross-bridge detachment → faster relaxation; this would be impaired
D) Increase in L-type Ca2+ current
E) PLN phosphorylation

Explanation: β1-adrenergic stimulation via PKA phosphorylates multiple targets: PLN (faster SR Ca2+ uptake), L-type channels (more Ca2+ entry), AND cardiac TnI (reduces TnC-Ca2+ affinity, promoting faster Ca2+ release from troponin, accelerating cross-bridge detachment and relaxation). In the transgenic mouse where TnI cannot be phosphorylated, lusitropy (relaxation rate) would be specifically impaired because the Ca2+-TnC dissociation step would remain slow even with elevated PKA activity. Inotropy would be largely preserved through PLN + L-type channel phosphorylation.

SUMMARY TABLES FOR QUICK REVIEW

Contractile Protein Quick Reference

Protein	Location	Function	Clinical Relevance
Myosin (heavy chain)	Thick filament	ATPase motor; force + velocity	Isoform determines fiber type
Actin (G/F)	Thin filament	Track for myosin; activates ATPase	Links to dystrophin via α-actinin
Tropomyosin	Thin filament groove	Blocks myosin-binding sites at rest	-
Troponin C	Every 7 actins	Binds Ca2+ to initiate contraction	cTnT/cTnI are cardiac biomarkers
Troponin I	Every 7 actins	Inhibitory; binds actin	PKA target (lusitropy)
Troponin T	Every 7 actins	Anchors troponin to tropomyosin	-
Titin	Z disk to M line	Elastic spring; passive tension	Mutations → dilated cardiomyopathy
Dystrophin	Sarcolemma-cytoskeleton	Mechanical linker	Mutated in DMD/BMD
Calmodulin	Cytoplasm (smooth)	Ca2+ sensor replacing troponin	Universal Ca2+ signal transducer
MLCK	Smooth/cardiac	Phosphorylates MLC-20	Target of Ca2+-calmodulin pathway

Key Calcium Concentrations

State	[Ca2+]i	Troponin C Occupancy
Rest	~10-7 M	~9%
Threshold for contraction	~10-6 M	~50%
Full activation	~10-5 M	~91%

SR Calcium Handling Proteins

Protein	Function	Drug Affecting It
RyR1	SR Ca2+ release (skeletal)	Dantrolene (block), Caffeine (activate), Volatile anesthetics (trigger in MH)
RyR2	SR Ca2+ release (cardiac)	-
SERCA	SR Ca2+ reuptake	Thapsigargin (block), improved by PLN phosphorylation
Phospholamban (PLN)	Inhibits SERCA (cardiac)	Phosphorylated by PKA (β1 stimulation) → disinhibits SERCA
DHPR	Voltage sensor / L-type Ca2+ channel	Verapamil/diltiazem (block), dihydropyridines

Sources:

Guyton and Hall Textbook of Medical Physiology 14e, pp. 93-125
Costanzo Physiology 7e, pp. 150-155
Miller's Review of Orthopaedics 9e, p. 69-71
Rheumatology 2-Volume Set (Elsevier 2022), pp. 1420-1422
Morgan & Mikhail's Clinical Anesthesiology 7e
Recent reviews: Structural Biochemistry of Muscle Contraction, Annu Rev Biochem 2023 (PMID 37001141); Molecular Mechanisms of Muscle Contraction - A Historical Perspective, J Biomech 2023 (PMID 37290181); Skeletal Muscle Structure, Physiology & Function, Handb Clin Neurol 2023 (PMID 37562874); Recent Advances in Skeletal Muscle Physiology, BJA Education 2024 (PMID 38375493)

This is a shared conversation. Sign in to Orris to start your own chat.